These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6852994)

  • 1. The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
    Waxman HL
    Int J Cardiol; 1983 Apr; 3(1):76-80. PubMed ID: 6852994
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
    McGovern B; Ruskin JN
    Int J Cardiol; 1983 Apr; 3(1):71-6. PubMed ID: 6852993
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
    Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
    Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone for ventricular arrhythmias.
    N Engl J Med; 1981 Dec; 305(26):1587-9. PubMed ID: 7312002
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
    Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic actions of amiodarone.
    Anderson GJ
    Am Fam Physician; 1982 Apr; 25(4):178-80. PubMed ID: 6461234
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
    Van Schepdael J; Solvay H
    Schweiz Rundsch Med Prax; 1975 Jan; 64(2):30-4. PubMed ID: 56002
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L
    Schweiz Med Wochenschr; 1990 Jun; 120(25):941-5. PubMed ID: 1695020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular flutter during treatment with amiodarone.
    Cui G; Huang W; Urthaler F
    Am J Cardiol; 1983 Feb; 51(3):609-10. PubMed ID: 6823876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.